Immuneering Corporation

NASDAQ:IMRX

2.28 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 00-94.419094.419000.0380.0940.1840.190.4820.660.7480.6650.6830.4810.483
Kosten van de omzet 0.1750.1880.1850.1960.1940.19157.9640.0190.0480.0910.2060.2190.3190.4090.4730.3150.2370.255
Brutowinst -0.175-0.188-94.604-0.19694.225-0.19-157.9630.0190.0460.093-0.0170.2630.3410.3390.1920.3680.2440.228
Brutowinstmarge 001.00200.9980-346,411.0130.4960.4920.505-0.0880.5460.5170.4530.2880.5390.5070.472
Onderzoek- en ontwikkelingskosten 10.5911.14111.9110.059.45310.2119.8729.3647.9819.0597.956.2076.9925.3914.894.0693.2212.823
Algemene en administratieve kosten 4.2544.1164.3853.8694.0454.4614.1063.8363.7043.9523.1492.5991.341.1841.1380.6990.6290.644
Verkoop- en marketingkosten -4,250.325-0.1190000000000000000
Verkoop-, algemene en administratieve kosten 4.1483.9974.3853.8694.0454.4614.1063.8363.7043.9523.1492.5991.341.1841.1380.6990.6290.644
Overige kosten 0.0080.2130.4640.0070.150.0070.0070.007-0.0240.008-0.119-0.008000000
Bedrijfskosten 14.73815.13816.30313.92613.50514.67913.98513.20711.69213.01911.0998.8068.3326.5756.0284.7683.853.467
Bedrijfsresultaat -14.914-15.326-16.302-13.926-13.505-14.68-13.985-13.188-11.646-12.926-11.116-8.543-7.991-6.236-5.836-4.4-3.607-3.239
Bedrijfsresultaat ratio 000.1730-0.1430-30,668.875-343.62-123.344-70.364-58.63-17.72-12.107-8.335-8.776-6.447-7.501-6.706
Totaal overige inkomsten en kosten netto 0.8341.0180.4641.3310.151.0760.7390.344-0.0240.029-0.119-0.0080.0040.00600.0010.0030.038
Inkomen voor belasting -14.08-14.308-15.084-12.595-12.189-13.604-13.246-12.844-11.527-12.897-11.092-8.534-7.987-6.23-5.836-4.399-3.604-3.201
Inkomen voor belasting ratio 000.160-0.1290-29,047.285-334.661-122.085-70.205-58.504-17.701-12.101-8.326-8.775-6.445-7.495-6.626
Belastingkosten -0-0-0.755-13,912.372-1.139-1,075.403-0.74-0.344-0.052-0.029-0.307-0.0170.00100.042-00.0010
Nettowinst -14.08-14.308-15.083-12.595-12.1891,061.799-12.506-12.501-11.527-12.867-10.784-8.534-7.988-6.23-5.836-4.399-3.604-3.201
Nettowinstmarge 000.160-0.1290-27,424.346-325.704-122.087-70.045-56.882-17.701-12.102-8.326-8.775-6.445-7.496-6.626
WPA (Winst Per Aandeel) -0.47-0.49-0.52-0.43-0.4340.16-0.47-0.47-0.44-0.49-0.42-0.47-0.33-0.46-0.43-0.33-0.27-0.24
Verwaterde WPA -0.47-0.49-0.52-0.43-0.4340.16-0.47-0.47-0.44-0.49-0.42-0.47-0.33-0.46-0.43-0.33-0.27-0.24
EBITDA -14.738-15.138-16.205-13,926.338-13.498-14.49-13.978-12.984-11.639-12.725-11.116-8.506-7.955-6.202-5.762-4.385-3.59-3.224
EBITDA ratio 000.1720-0.1430-30,652.829-338.29-123.265-69.272-58.63-17.642-12.053-8.289-8.663-6.424-7.467-6.674